A review and new report of medial temporal lobe dysfunction as a vulnerability indicator for schizophrenia: a magnetic resonance imaging morphometric family study of the parahippocampal gyrus.

PubWeight™: 1.34‹?› | Rank: Top 10%

🔗 View Article (PMID 14989416)

Published in Schizophr Bull on January 01, 2003

Authors

Larry J Seidman1, Christos Pantelis, Matcheri S Keshavan, Stephen V Faraone, Jill M Goldstein, Nicholas J Horton, Nikos Makris, Peter Falkai, Verne S Caviness, Ming T Tsuang

Author Affiliations

1: Commonwealth Research Center, Harvard Medical School, Department of Psychiatry, Massachusetts Mental Health Center, Boston, MA, USA. larry_seidman@hms.harvard.edu

Articles citing this

Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research. Schizophr Bull (2005) 2.50

A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia. Neuron (2010) 1.96

A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia. Biol Psychiatry (2006) 1.93

Emotion processing in persons at risk for schizophrenia. Schizophr Bull (2008) 1.31

A schizophrenia risk gene, ZNF804A, influences neuroanatomical and neurocognitive phenotypes. Neuropsychopharmacology (2010) 1.21

Are we studying and treating schizophrenia correctly? Schizophr Res (2011) 1.19

Cortical gray and white matter volume in unmedicated schizotypal and schizophrenia patients. Schizophr Res (2008) 1.07

Hippocampal subdivision and amygdalar volumes in patients in an at-risk mental state for schizophrenia. J Psychiatry Neurosci (2010) 1.04

Premorbid cognitive deficits in young relatives of schizophrenia patients. Front Hum Neurosci (2010) 1.01

Early and broadly defined psychosis risk mental states. Schizophr Res (2010) 1.01

CSF metabolic and proteomic profiles in patients prodromal for psychosis. PLoS One (2007) 0.99

Cognitive performance is related to cortical grey matter volumes in early stages of schizophrenia: a population-based study of first-episode psychosis. Schizophr Res (2009) 0.98

Functional magnetic resonance imaging (fMRI) of attention processes in presumed obligate carriers of schizophrenia: preliminary findings. Ann Gen Psychiatry (2008) 0.97

The effect of cannabis on the brain: can it cause brain anomalies that lead to increased risk for schizophrenia? Curr Opin Psychiatry (2008) 0.95

Smoking status as a potential confounder in the study of brain structure in schizophrenia. J Psychiatr Res (2013) 0.92

Reduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders. Schizophr Bull (2014) 0.91

Commentary: The schizophrenia prodrome: a high-risk concept. Schizophr Bull (2003) 0.91

DTNBP1 is associated with imaging phenotypes in schizophrenia. Hum Brain Mapp (2009) 0.89

White matter volume abnormalities and associations with symptomatology in schizophrenia. Psychiatry Res (2010) 0.88

Cortical mapping of genotype-phenotype relationships in schizophrenia. Hum Brain Mapp (2007) 0.87

Altered amygdala connectivity within the social brain in schizophrenia. Schizophr Bull (2013) 0.87

Toward a model of memory enhancement in schizophrenia: glucose administration and hippocampal function. Schizophr Bull (2007) 0.86

The effect of neurogranin on neural correlates of episodic memory encoding and retrieval. Schizophr Bull (2011) 0.86

Reduced parahippocampal cortical thickness in subjects at ultra-high risk for psychosis. Psychol Med (2013) 0.84

Hippocampal physiology, structure and function and the neuroscience of schizophrenia: a unified account of declarative memory deficits, working memory deficits and schizophrenic symptoms. Behav Sci (Basel) (2013) 0.83

Using structural neuroimaging to make quantitative predictions of symptom progression in individuals at ultra-high risk for psychosis. Front Psychiatry (2014) 0.83

Commentary: Progress, issues, and implications of prodromal research: an inside view. Schizophr Bull (2003) 0.83

Structural abnormalities in language circuits in genetic high-risk subjects and schizophrenia patients. Psychiatry Res (2012) 0.81

A comparative study on long-term evoked auditory and visual potential responses between Schizophrenic patients and normal subjects. BMC Psychiatry (2011) 0.79

Hippocampal temporal-parietal junction interaction in the production of psychotic symptoms: a framework for understanding the schizophrenic syndrome. Front Hum Neurosci (2012) 0.79

Neuroimaging of schizophrenia: structural abnormalities and pathophysiological implications. Neuropsychiatr Dis Treat (2005) 0.78

Sex and laterality differences in parkinsonian impairment and transcranial ultrasound in never-treated schizophrenics and their first degree relatives in an Andean population. Schizophr Res (2015) 0.78

Neurocognitive and clinical dysfunction in adult Chinese, nonpsychotic relatives of patients with schizophrenia: Findings from the Changsha study and evidence for schizotaxia. Asian J Psychiatr (2012) 0.77

Genetic variation in GAD1 is associated with cortical thickness in the parahippocampal gyrus. J Psychiatr Res (2013) 0.77

Alterations of lateral temporal cortical gray matter and facial memory as vulnerability indicators for schizophrenia: An MRI study in youth at familial high-risk for schizophrenia. Schizophr Res (2015) 0.76

Thalamic nuclear abnormalities as a contributory factor in sudden cardiac deaths among patients with schizophrenia. Clinics (Sao Paulo) (2010) 0.75

Commentary: Chickens and eggs; carts and horses: an outsider's perspective on the study of the early stages and potential prevention of psychosis and schizophrenia. Schizophr Bull (2003) 0.75

Similar and different gray matter deficits in schizophrenia patients and their unaffected biological relatives. Front Psychiatry (2013) 0.75

Hyperactivity of caudate, parahippocampal, and prefrontal regions during working memory in never-medicated persons at clinical high-risk for psychosis. Schizophr Res (2016) 0.75

Articles by these authors

Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron (2002) 33.99

Automatically parcellating the human cerebral cortex. Cereb Cortex (2004) 18.32

New models of collaboration in genome-wide association studies: the Genetic Association Information Network. Nat Genet (2007) 13.76

The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry (2006) 11.85

Sequence-independent segmentation of magnetic resonance images. Neuroimage (2004) 11.36

High angular resolution diffusion imaging reveals intravoxel white matter fiber heterogeneity. Magn Reson Med (2002) 8.89

Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02

Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review. Biol Psychiatry (2005) 7.90

Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade and manufacturer. Neuroimage (2006) 7.14

Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet (2003) 6.63

Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia. Proc Natl Acad Sci U S A (2009) 6.09

Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology. Schizophr Res (2008) 5.99

Attention-deficit hyperactivity disorder. Lancet (2005) 5.75

Genomewide association studies: history, rationale, and prospects for psychiatric disorders. Am J Psychiatry (2009) 4.74

Brief intervention for medical inpatients with unhealthy alcohol use: a randomized, controlled trial. Ann Intern Med (2007) 4.73

Segmentation of subcomponents within the superior longitudinal fascicle in humans: a quantitative, in vivo, DT-MRI study. Cereb Cortex (2004) 4.50

Whole-brain anatomical networks: does the choice of nodes matter? Neuroimage (2009) 4.43

Localization of white matter volume increase in autism and developmental language disorder. Ann Neurol (2004) 4.40

Clozapine alone versus clozapine and risperidone with refractory schizophrenia. N Engl J Med (2006) 4.16

Strategy for intention to treat analysis in randomised trials with missing outcome data. BMJ (2011) 4.12

Schizophrenia, "just the facts" 4. Clinical features and conceptualization. Schizophr Res (2009) 3.68

At clinical high risk for psychosis: outcome for nonconverters. Am J Psychiatry (2011) 3.66

Effects of age on volumes of cortex, white matter and subcortical structures. Neurobiol Aging (2005) 3.63

Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Arch Gen Psychiatry (2006) 3.62

MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: Reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths. Neuroimage (2009) 3.57

Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study. Psychol Med (2006) 3.57

Hippocampal plasticity in response to exercise in schizophrenia. Arch Gen Psychiatry (2010) 3.42

Addiction, a condition of compulsive behaviour? Neuroimaging and neuropsychological evidence of inhibitory dysregulation. Addiction (2004) 3.34

Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology (2009) 3.27

Pharmacologic treatments for pediatric bipolar disorder: a review and meta-analysis. J Am Acad Child Adolesc Psychiatry (2011) 3.26

Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. Am J Hum Genet (2005) 3.24

Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcohol Clin Exp Res (2004) 3.24

Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder. Biol Psychiatry (2006) 3.17

Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2010) 3.13

Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. Am J Psychiatry (2003) 3.12

Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. J Affect Disord (2008) 2.95

Early life programming and neurodevelopmental disorders. Biol Psychiatry (2010) 2.93

Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch Gen Psychiatry (2007) 2.91

Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull (2009) 2.90

Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication. Biol Psychiatry (2005) 2.87

The integrated response of the human cerebro-cerebellar and limbic systems to acupuncture stimulation at ST 36 as evidenced by fMRI. Neuroimage (2005) 2.86

Distinctive neurocognitive effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in major depression. Br J Psychiatry (2005) 2.84

Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics (2003) 2.79

Brain structures in pediatric maltreatment-related posttraumatic stress disorder: a sociodemographically matched study. Biol Psychiatry (2002) 2.74

Assessing missed opportunities for HIV testing in medical settings. J Gen Intern Med (2004) 2.72

Characterization of the "deqi" response in acupuncture. BMC Complement Altern Med (2007) 2.70

Adolescent alcohol use is a risk factor for adult alcohol and drug dependence: evidence from a twin design. Psychol Med (2005) 2.66

Case-control study of attention-deficit hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy. J Am Acad Child Adolesc Psychiatry (2002) 2.65

Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry (2006) 2.60

Genome-wide association studies in ADHD. Hum Genet (2009) 2.58

Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders. Biol Psychiatry (2009) 2.57

Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis. Arch Gen Psychiatry (2010) 2.54

Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum Mol Genet (2006) 2.53

Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. Am J Med Genet B Neuropsychiatr Genet (2008) 2.53

Attention-deficit/hyperactivity disorder in adults. JAMA (2004) 2.50

Schizophrenia, neuroimaging and connectomics. Neuroimage (2012) 2.49

Language-association cortex asymmetry in autism and specific language impairment. Ann Neurol (2004) 2.49

Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. Eur Child Adolesc Psychiatry (2006) 2.49

Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3. Am J Psychiatry (2012) 2.48

Functional impairments in adults with self-reports of diagnosed ADHD: A controlled study of 1001 adults in the community. J Clin Psychiatry (2006) 2.48

Schizophrenia, "just the facts" 5. Treatment and prevention. Past, present, and future. Schizophr Res (2010) 2.47

microRNA-34c is a novel target to treat dementias. EMBO J (2011) 2.44

Cortical thinning of the attention and executive function networks in adults with attention-deficit/hyperactivity disorder. Cereb Cortex (2006) 2.44

Structural brain imaging of attention-deficit/hyperactivity disorder. Biol Psychiatry (2005) 2.40

Three potential susceptibility loci shown by a genome-wide scan for regions influencing the age at onset of mania. Am J Psychiatry (2004) 2.40

Genome-wide association scan of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet (2008) 2.40

Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry (2002) 2.37

Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report. Am J Med Genet B Neuropsychiatr Genet (2005) 2.34

Differences in resting-state functional magnetic resonance imaging functional network connectivity between schizophrenia and psychotic bipolar probands and their unaffected first-degree relatives. Biol Psychiatry (2012) 2.33

Alcohol consumption and HIV disease progression: are they related? Alcohol Clin Exp Res (2003) 2.32

Adult psychiatric outcomes of girls with attention deficit hyperactivity disorder: 11-year follow-up in a longitudinal case-control study. Am J Psychiatry (2010) 2.31

Impact of executive function deficits and attention-deficit/hyperactivity disorder (ADHD) on academic outcomes in children. J Consult Clin Psychol (2004) 2.30

Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. Proc Natl Acad Sci U S A (2005) 2.29

Hierarchical genetic organization of human cortical surface area. Science (2012) 2.28

Effect of long-term cannabis use on axonal fibre connectivity. Brain (2012) 2.27

Clinical staging: a heuristic model for psychiatry and youth mental health. Med J Aust (2007) 2.25

Hormonal cycle modulates arousal circuitry in women using functional magnetic resonance imaging. J Neurosci (2005) 2.25

Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder. Br J Psychiatry (2013) 2.21

Behavioral inhibition in preschool children at risk is a specific predictor of middle childhood social anxiety: a five-year follow-up. J Dev Behav Pediatr (2007) 2.20

Medical comorbidity in schizophrenia. Med J Aust (2003) 2.20

Structural brain magnetic resonance imaging of limbic and thalamic volumes in pediatric bipolar disorder. Am J Psychiatry (2005) 2.18

Prefrontal cortex, thalamus, and cerebellar volumes in adolescents and young adults with adolescent-onset alcohol use disorders and comorbid mental disorders. Alcohol Clin Exp Res (2005) 2.16

Modulation of brain resting-state networks by sad mood induction. PLoS One (2008) 2.15

Decreased volume of the brain reward system in alcoholism. Biol Psychiatry (2008) 2.15

Effects of electroacupuncture versus manual acupuncture on the human brain as measured by fMRI. Hum Brain Mapp (2005) 2.15

Altered corticostriatal functional connectivity in obsessive-compulsive disorder. Arch Gen Psychiatry (2009) 2.13

Normative data from the CANTAB. I: development of executive function over the lifespan. J Clin Exp Neuropsychol (2003) 2.12

Disrupted axonal fiber connectivity in schizophrenia. Biol Psychiatry (2010) 2.12

Consistency and functional specialization in the default mode brain network. Proc Natl Acad Sci U S A (2008) 2.12

Cortical surface shape analysis based on spherical wavelets. IEEE Trans Med Imaging (2007) 2.11

Environmental risk factors for attention-deficit hyperactivity disorder. Acta Paediatr (2007) 2.10